These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2452977)

  • 1. [Status of determining the transepithelial potential difference (PD) of the respiratory epithelium in the diagnosis of mucoviscidosis].
    Unal-Maelger OH; Urbanek R
    Monatsschr Kinderheilkd; 1988 Feb; 136(2):76-80. PubMed ID: 2452977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased nasal potential difference and amiloride sensitivity in neonates with cystic fibrosis.
    Gowen CW; Lawson EE; Gingras-Leatherman J; Gatzy JT; Boucher RC; Knowles MR
    J Pediatr; 1986 Apr; 108(4):517-21. PubMed ID: 3958823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative ion permeability of normal and cystic fibrosis nasal epithelium.
    Knowles M; Gatzy J; Boucher R
    J Clin Invest; 1983 May; 71(5):1410-7. PubMed ID: 6853720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination of nasal transepithelial potential difference (DDPTE) in cystic fibrosis. Analysis of a simplified measurement technique].
    Labbé A; Bellon G; Héraud MC; Arbre P; Goddon G; Alton E
    Arch Fr Pediatr; 1991 Nov; 48(9):617-20. PubMed ID: 1722389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis.
    Knowles M; Gatzy J; Boucher R
    N Engl J Med; 1981 Dec; 305(25):1489-95. PubMed ID: 7300874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of airway ion transport assists the diagnosis of cystic fibrosis.
    Middleton PG; House HH
    Pediatr Pulmonol; 2010 Aug; 45(8):789-95. PubMed ID: 20597077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protocols for in vivo measurement of the ion transport defects in cystic fibrosis nasal epithelium.
    Middleton PG; Geddes DM; Alton EW
    Eur Respir J; 1994 Nov; 7(11):2050-6. PubMed ID: 7875281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical application of transepithelial potential difference measurements in cystic fibrosis.
    Sauder RA; Chesrown SE; Loughlin GM
    J Pediatr; 1987 Sep; 111(3):353-8. PubMed ID: 2442338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conventional and modified nasal potential-difference measurement in cystic fibrosis.
    Höfmann T; Bohmer O; Hüls G; Terbrack HG; Bittner P; Klingmüller V; Heerd E; Lindemann H
    Am J Respir Crit Care Med; 1997 Jun; 155(6):1908-13. PubMed ID: 9196094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transepithelial potential difference in cystic fibrosis.
    Hay JG; Geddes DM
    Thorax; 1985 Jul; 40(7):493-6. PubMed ID: 4035615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nasal transepithelial difference of potential in mucoviscidosis. Clinical application of the measurement].
    Maherzi A; Ategbo S; Pharaon I; Munck A; Cezard JP; Foucaud P; Navarro J
    Presse Med; 1995 Mar; 24(9):437-40. PubMed ID: 7746816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal apical cell membrane in cystic fibrosis respiratory epithelium. An in vitro electrophysiologic analysis.
    Cotton CU; Stutts MJ; Knowles MR; Gatzy JT; Boucher RC
    J Clin Invest; 1987 Jan; 79(1):80-5. PubMed ID: 3793933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of topically delivered benzamil and amiloride on nasal potential difference in cystic fibrosis.
    Hofmann T; Stutts MJ; Ziersch A; Rückes C; Weber WM; Knowles MR; Lindemann H; Boucher RC
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1844-9. PubMed ID: 9620916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis.
    Knowles MR; Paradiso AM; Boucher RC
    Hum Gene Ther; 1995 Apr; 6(4):445-55. PubMed ID: 7542031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colonic and esophageal transepithelial potential difference in cystic fibrosis.
    Orlando RC; Powell DW; Croom RD; Berschneider HM; Boucher RC; Knowles MR
    Gastroenterology; 1989 Apr; 96(4):1041-8. PubMed ID: 2925051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Measurement of nasal transepithelial potential difference: a diagnostic test for cystic fibrosis].
    Charfi MR; Matran R; Regnard J; Lockhart A
    Rev Pneumol Clin; 1996; 52(1):9-13. PubMed ID: 8731749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in vivo effects of milrinone on the airways of cystic fibrosis mice and human subjects.
    Smith SN; Middleton PG; Chadwick S; Jaffe A; Bush KA; Rolleston S; Farley R; Delaney SJ; Wainwright B; Geddes DM; Alton EW
    Am J Respir Cell Mol Biol; 1999 Jan; 20(1):129-34. PubMed ID: 9870926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal potential difference: a clinical diagnostic test for cystic fibrosis.
    Alton EW; Currie D; Logan-Sinclair R; Warner JO; Hodson ME; Geddes DM
    Eur Respir J; 1990 Sep; 3(8):922-6. PubMed ID: 2292287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter study of the effect of solution temperature on nasal potential difference measurements.
    Boyle MP; Diener-West M; Milgram L; Knowles M; Foy C; Zeitlin P; Standaert T;
    Chest; 2003 Aug; 124(2):482-9. PubMed ID: 12907532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of topical benzamil and amiloride on nasal potential difference in cystic fibrosis.
    Rodgers HC; Knox AJ
    Eur Respir J; 1999 Sep; 14(3):693-6. PubMed ID: 10543294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.